You can buy Cabodx at the lowest price at Nextgen.ooo online pharmacy. Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
 
It was initially approved in the US under the brand name Cometriq, which is indicated for the treatment of metastatic medullary thyroid cancer. In 2016, the drug in capsule form (Cabometyx) was approved for the treatment of advanced renal cell carcinoma, and the same drug received additional approval in both the US and Canada in 2019 for the treatment of hepatocellular carcinoma in previously treated patients.
Cabozantinib is indicated for the treatment of advanced metastatic medullary thyroid cancer. It is also indicated for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma in patients previously treated with sorafenib.
Cabozantinib inhibits metastasis, angiogenesis, and tumorigenesis by inhibiting receptor tyrosine kinases.
Cabozantinib inhibits specific receptor tyrosine kinases such as VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2.